Cramer Calls CLOV a Correct Speculative Bet but Favors UNH, CVS
Jim Cramer acknowledges Clover Health as a profitable speculative pick but reaffirms preference for UnitedHealth and CVS for long-term holdings. Jim Cramer labeled Clover Health Investments (NASDAQ:CLOV) a successful speculative investment after the company reported GAAP p